Loading
BioPharma Dive
BioPharma Dive offers clean, free industry reporting and is good for deal and approval context.
Overview
BioPharma Dive offers clean, free industry reporting on approvals, trial results, mergers and acquisitions and policy, and is good for deal and approval context. It publishes daily and is run by Industry Dive, part of Informa. Access is free without a paywall, which sets it apart from the subscription industry titles. On OnCo it is listed as a source with the tags source and news, read for the industry side of oncology and for context on deals and approvals when a free explainer is needed.
Holds
Industry news: approvals, trial results, M&A, policy.
Licence
Free
Maintainer
Industry Dive (Informa)
Connected
3Similar pages
- CollectionSTAT News
Shares Nimbus Therapeutics and the tags source, news.
- CollectionADC Review
Shares the tags source, news.
- CollectionASCO Daily News
Shares the tags source, news.
- CollectionThe ASCO Post
Shares the tags source, news.
- CollectionBioCentury
Shares the tags source, news.
- CollectionThe Cancer Letter
Shares the tags source, news.
- CollectionCancerNetwork (ONCOLOGY)
Shares the tags source, news.
- CollectionEndpoints News
Shares the tags source, news.
Sources
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
biopharmadive.com · 1
A source that has moved or gone is reported by the weekly link check. /audit/